Metabolic Syndrome News and Research

Latest Metabolic Syndrome News and Research

Caffeine consumption reduces risk of advanced fibrosis in NAFLD patients

Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces the risk of advanced fibrosis in those with nonalcoholic fatty liver disease (NAFLD).

3 Feb 2012

Sugar should be controlled to protect public health: UCSF

Sugar should be controlled like alcohol and tobacco to protect public health, according to a team of UCSF researchers, who maintain in a new report that sugar is fueling a global obesity pandemic, contributing to 35 million deaths annually worldwide from non-communicable diseases like diabetes, heart disease and cancer.

2 Feb 2012

Pros and cons of routine school BMI screening

The value of routine body mass index (BMI) screening in schools has been a topic of ongoing controversy. An expert Roundtable Discussion in the current issue of Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc., debates the pros and cons of routine BMI screening in the school setting, discusses the most recent data, and explores when and for what purpose BMI screening results should be shared with parents and the potential benefits.

2 Feb 2012

Diet soft drink consumption may increase risk of vascular events

Individuals who drink diet soft drinks on a daily basis may be at increased risk of suffering vascular events such as stroke, heart attack, and vascular death. This is according to a new study by Hannah Gardener and her colleagues from the University of Miami Miller School of Medicine and at Columbia University Medical Center.

1 Feb 2012

Genetic variation predisposes children to complications linked with second-generation anti-psychotics

Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease.

25 Jan 2012

Study shows childhood experiences have long-term effects on health in midlife

Nurturing mothers have garnered accolades for rescuing skinned knees on the playground and coaxing their children to sleep with lullabies. Now they're gaining merit for their offspring's physical health in middle age.

24 Jan 2012

The AJMS publishes updates on type 2 diabetes, STIs

Research is leading to new insights on two major public health challenges: preventing the spread of sexually transmitted infections (STIs) and improving disease control for patients with type 2 diabetes. Expert updates on these critical topics appear in a special symposium section of the January issue of The American Journal of the Medical Sciences (The AJMS), official journal of the Southern Society for Clinical Investigation.

19 Jan 2012

N.Y. cardiologist to discuss metabolic conditions at The Jeremy Kyle Show

The New York Cardiac Diagnostic Center announced today Dr. Steven Reisman, a New York City cardiologist, will be featured on an upcoming episode of The Jeremy Kyle Show. Dr. Reisman will be discussing the increased risk for heart disease, type 2 diabetes and metabolic syndrome for individuals who are overweight or obese.

19 Jan 2012

Spherix completes SPX-106 28-day rat toxicology study

Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.

11 Jan 2012

Natural options against weight gain, sugar cravings, and insulin resistance

The holidays have come and gone, but many of us may still be battling intense sweet cravings leftover from the season's festivities. Excessive sugar cravings can be a sign that your blood glucose levels are out of balance which, if left unchecked, can lead to insulin resistance and Metabolic Syndrome, also known as "Pre-Diabetes."

11 Jan 2012

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

Charles H. Hennekens, M.D., DrPH, the first Sir Richard Doll Research Professor as well as first recipient of an endowed chair in the new Charles E. Schmidt College of Medicine at Florida Atlantic University, has published a Citation Classic in the current issue of Clinical Chemistry. Hennekens was the founding principal investigator (PI) of the landmark Physician's Health Study and was the first to demonstrate that aspirin prevents a first heart attack.

7 Jan 2012

CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

The Seventh International Conference on Cell Therapy for Cardiovascular Disease sponsored by the Cardiovascular Research Foundation (CRF) is a comprehensive program dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

5 Jan 2012

The Academy of Nutrition and Dietetics to expand coverage of MNT

The Academy of Nutrition and Dietetics has prepared a request to submit to the Centers for Medicare and Medicaid Services (CMS) to expand coverage of medical nutrition therapy (MNT) for specific diseases, including hypertension, obesity, and cancer, as part of the CMS National Coverage Determination (NCD) Process.

19 Dec 2011

INT-777 shows promise against metabolic syndrome

Heart disease is a major cause of death in industrialised countries, and is strongly associated with obesity and diabetes. Many scientists believe that what links these conditions is a chronic, low-grade inflammation.

7 Dec 2011

Fatty livers burn more fat, not less

When our livers become loaded with fat, it isn't because they are slacking. A new study of human patients in the December Cell Metabolism shows that fatty livers actually burn more fat, not less. All that "hard work" may be at the root of the organ damage that comes with nonalcoholic fatty liver disease (NAFLD), a condition associated with insulin resistance that affects about one in three in the U.S. population.

6 Dec 2011

Subconscious nervous impulses may be prognostic markers for weight-loss outcome

A recent study of obese volunteers participating in a 12-week dietary weight-loss program found that successful weight losers had significantly higher resting nerve activity compared to weight-loss resistant individuals.

5 Dec 2011

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.

28 Nov 2011

ABCC9 gene also influences duration of sleep in humans

A collaborative European study led by LMU researchers has shown that ABCC9, a known genetic factor in heart disease and diabetes, also influences the duration of sleep in humans.

24 Nov 2011

CUMC presents 2011 Naomi Berrie Award to UMDNJ researcher

Columbia University Medical Center (CUMC) presented the 2011 Naomi Berrie Award to Barry E. Levin, MD, a University of Medicine & Dentistry of New Jersey researcher whose work focuses on the mechanisms by which specialized metabolic-sensing neurons regulate glucose and energy homeostasis. Junior investigator Kazuhisa Watanabe, at Columbia University Medical Center, received a Berrie Fellow award.

22 Nov 2011

Study: Metabolic syndrome biomarkers predict decline in lung function after WTC dust exposure

Metabolic syndrome biomarkers predict subsequent decline in lung function after particulate exposure, according to new research involving rescue personnel exposed to World Trade Center (WTC) dust.

19 Nov 2011

Metabolic Syndrome News and Research

Latest Metabolic Syndrome News and Research

Caffeine consumption reduces risk of advanced fibrosis in NAFLD patients

Sugar should be controlled to protect public health: UCSF

Pros and cons of routine school BMI screening

Diet soft drink consumption may increase risk of vascular events

Genetic variation predisposes children to complications linked with second-generation anti-psychotics

Study shows childhood experiences have long-term effects on health in midlife

The AJMS publishes updates on type 2 diabetes, STIs

N.Y. cardiologist to discuss metabolic conditions at The Jeremy Kyle Show

Spherix completes SPX-106 28-day rat toxicology study

Natural options against weight gain, sugar cravings, and insulin resistance

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

The Academy of Nutrition and Dietetics to expand coverage of MNT

INT-777 shows promise against metabolic syndrome

Fatty livers burn more fat, not less

Subconscious nervous impulses may be prognostic markers for weight-loss outcome

FDA grants IND for AEZS-130 Phase 2A trial in cancer cachexia

ABCC9 gene also influences duration of sleep in humans

CUMC presents 2011 Naomi Berrie Award to UMDNJ researcher

Study: Metabolic syndrome biomarkers predict decline in lung function after WTC dust exposure

eBook: Integrated solutions for metabolic disease drug development eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Metabolic Syndrome News and Research

Latest Metabolic Syndrome News and Research

eBook: Integrated solutions for metabolic disease drug development eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in